Skip to Main content Skip to Navigation
Journal articles

Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.

Abstract : We examined the capacity of delayed inhibition of plasminogen activator inhibitor-1 (PAI-1) to reduce tubulointerstitial fibrosis induced by unilateral ureteral obstruction (UUO) in mice. Small peptides mimicking parts of urokinase (uPA) and tissular plasminogen activator (tPA) and serving as decoy molecules for PAI-1 were administered daily during the late stages (3 to 8 days) of UUO. Treatment with PAI-1 decoys reduced interstitial deposition of fibronectin, collagen III and collagen IV without changes in macrophage and myofibroblast infiltration. Interestingly, while PAI-1 activity was reduced and the combined uPA and tPA activity was increased, the antifibrotic effect was obtained without modification of plasmin activity but with increased of hepatocyte growth factor (HGF) expression. We show for the first time that treatment with small PAI-1 decoy peptides reduces established tubulointerstitial fibrosis. This protective effect probably resulted from increased degradation of the extracellular matrix by an HGF dependent mechanism.
Document type :
Journal articles
Complete list of metadata
Contributor : Marie Francoise Simon Connect in order to contact the contributor
Submitted on : Wednesday, May 5, 2010 - 11:55:12 AM
Last modification on : Monday, July 4, 2022 - 9:44:24 AM




Julien Gonzalez, Julie Klein, Sharmila D. Chauhan, Eric Neau, Denis Calise, et al.. Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.. Experimental biology and medicine (Maywood, N.J.), 2009, 234 (12), pp.1511-8. ⟨10.3181/0903-RM-105⟩. ⟨inserm-00480896⟩



Record views